View Research Profile

Publications

Peer-reviewed articles:

  • AA Liu, CE Boxhorn, MA Klufas, PJ Christos, JT Thorne, AY Shih, NM Tsankova, BJ Dorfman, C Henchcliffe, P Piboolnurak, and MJ Nirenberg.& Clinical predictors of frequent patient telephone calls in Parkinson's disease, Parkinsonism and Related Disorders, in press.& DOI: 10.1016/j.parkreldis.2010.10.014
  • K Kieburtz and the PramiBID Investigators including MJ Nirenberg. Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized placebo-controlled trial, Movement Disorders 2010; DOI: 10.1002/mds.23396. http://onlinelibrary.wiley.com/doi/10.1002/mds.23396/full
  • NR Khadem and MJ Nirenberg, Carbidopa/levodopa pharmacy errors in Parkinson's disease, Movement disorders 2010; DOI: 10.1002/mds.23311. http://onlinelibrary.wiley.com/doi/10.1002/mds.23311/abstract;jsessionid=D94299CA0E9CD90B4A2B000BC977A70C.d01t02
  • MJ Nirenberg and CA Rabinak. In Reply: Dopamine agonist withdrawal syndrome - The Apomorphine Solution, Archives of Neurology 2010; 67(9):1156. http://archneur.ama-assn.org/cgi/content/full/67/9/1156
  • MJ Nirenberg, Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery, Brain 2010; DOI: 10.1093/brain/awq165
    http://brain.oxfordjournals.org/cgi/content/full/awq165?ijkey=Kl6jjDqGjBND5Upkeytype=ref
  • CA Rabinak and MJ Nirenberg .& Dopamine agonist withdrawal syndrome in Parkinson disease, Archives of Neurology 2010; 67(1): 58-63.& archneur.ama-assn.org/cgi/content/full/67/1/58
  • MJ Nirenberg and C. Waters. Nocturnal eating in restless legs syndrome. Movement Disorders 2010 25(1): 126-127.& www3.interscience.wiley.com/journal/122613822/abstract
  • Henchcliffe, C, Shungu DC, Mao X, Huang C, Nirenberg, MJ, Jenkins BG, Beal MF. Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease, Annals of the New York Academy of Sciences 2008; 1147:206.& www3.interscience.wiley.com/journal/121554109/abstract
  • MJ Nirenberg, J. Libien, J-P. Vonsattel, and S. Fahn. Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation, Movement Disorders 2007; 22(2):251-254.& www3.interscience.wiley.com/journal/113489537/abstract
  • Nirenberg MJ and Waters C. Compulsive eating and weight gain related to dopamine agonist use, Movement Disorders 2005; 21(4): 524-529.& www3.interscience.wiley.com/journal/112138355/abstract
  • Pickel VM, Chan J, Nirenberg MJ. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Synapse 2002; 45:113-24. www3.interscience.wiley.com/journal/93521914/abstract
  • Pickel VM, Pohorille A, Chan J, Tate SS, Nirenberg MJ. Regional and subcellular distribution of a neutral and basic amino acid transporter in forebrain neurons containing nitric oxide synthase. J Comp Neurol 1999; 404:459-72.& www3.interscience.wiley.com/journal/40002761/abstract
  • Nirenberg MJ, Chan J, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J Neurosci 1997; 17:5255-62.& www.jneurosci.org/cgi/content/full/17/14/5255
  • Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM. Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals. Synapse 1997; 26:194-8.
  • Nirenberg MJ, Chan J, Pohorille A, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 1997; 17:6899-907. www.jneurosci.org/cgi/content/full/17/18/6899
  • Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 1996; 16:436-47.& www.jneurosci.org/cgi/reprint/16/2/436
  • Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J Neurosci 1996; 16:4135-45. www.jneurosci.org/cgi/content/full/16/13/4135
  • Nirenberg MJ, Tate SS, Mosckovitz R, Udenfriend S, Pickel VM. Immunocytochemical localization of the renal neutral and basic amino acid transporter in rat adrenal gland, brainstem, and spinal cord. J Comp Neurol 1995; 356:505-22.
  • Nirenberg MJ, Liu Y, Peter D, Edwards RH, Pickel VM. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc Natl Acad Sci USA 1995; 92:8773-7.& www.ncbi.nlm.nih.gov/pmc/articles/PMC41049/
  • Liu Y, Schweitzer ES, Nirenberg MJ, Pickel VM, Evans CJ, Edwards RH. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J Cell Biol 1994; 127:1419-33.& jcb.rupress.org/cgi/reprint/127/5/1419
  • Pickel VM, Nirenberg MJ, Chan J, Mosckovitz R, Udenfriend S, Tate SS. Ultrastructural localization of a neutral and basic amino acid transporter in rat kidney and intestine. Proc Natl Acad Sci USA 1993; 90:7779-83.& www.ncbi.nlm.nih.gov/pmc/articles/PMC47226/

    &

    Book Chapters & Review Articles:

  • Winterkorn JMS, Fraser CM, and Nirenberg MJ. Ophthalmic manifestations of neurodegenerative diseases.& In: FocalPoints in Ophthalmology, American Academy of Ophthalmology, 2010; 28(4):1-11.
  • Nirenberg MJ. Writer's Cramp. In: Squire L et al., eds. The New Encyclopedia of Neuroscience. Elsevier; 2008.
  • Nirenberg MJ, Fahn S. The use of levodopa and COMT inhibitors. In: Schapira AHV, Olanow CW, eds. Principles of Treatment in Parkinson's Disease, 7th Edition. New York, NY: Elsevier; 2005.
  • Nirenberg MJ, Ford B. Dystonic storm. In: Frucht SJ, Fahn S, eds. Movement disorders emergencies, diagnosis and treatment. Totowa, NJ: The Humana Press; 2005:101-109.
    Nirenberg MJ, Frucht SJ. Myoclonus. Curr Treat Options Neurol 2005; 7:221-230. www.treatment-options.com/cr_linkout_frmst.cfm
  • Kuhar MJ, Vaughan RA, Uhl GR, Cerruti C, Revay R, Freed C, Nirenberg MJ, Pickel VM. Localization of the dopmaine transporter protein by microscopic histochemistry. In: Goldstein DS, Eisenhofer G, McCarty R, eds. Advances in Pharmacology. Catecholamines: bridging basic science with clinical medicine. Vol. 42. San Diego, CA: Academic Press; 1998:168-170.
  • Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM. Ultrastructural localization of the vesicular monoamine transporter 2 in mesolimbic and nigrostriatal dopaminergic neurons. In: Goldstein DS, Eisenhofer G, McCarty R, eds. Advances in Pharmacology. Catecholamines: bridging basic science with clinical medicine. Vol. 42. San Diego, CA: Academic Press; 1998:240-3.
  • Pickel VM, Aicher SA, Aoki C, Cheng PY, Nirenberg MJ. Catecholamines, opioids, and vagal afferents in the nucleus of the solitary tract. In: Goldstein DS, Eisenhofer G, McCarty R, eds. Advances in Pharmacology. Catecholamines: bridging basic science with clinical medicine. Vol. 42. San Diego, CA: Academic Press; 1998:642-5.
  • Nirenberg MJ, Pickel VM. The vesicular and plasmalemmal dopamine transporters: ultrastructural localization in nigrostriatal dopaminergic neurons. In: Pogun S, ed. Proceedings of the NATO advanced research workshop on neurotransmitter release and update. Vol. 100. Heidelberg:Springer-Verlag; 1997:193-208.
  • Pickel VM, Nirenberg MJ, Milner TA. Ultrastructural view of central catecholaminergic transmission: immunocytochemical localization of synthesizing enzymes, transporters and receptors. J Neurocytol 1996; 25:843-56.

Back to topBack To Top